Our new report shows that workplace culture is a key determining factor in fitness to scale. Ed Lascelles says ‘Ignore it at your peril’. For the full study and recommendations
Click here20+ years
Experience of investing in technology
c. £450m
Venture capital currently invested
40+
Technology investments within our portfolio
UCLTF
In collaboration with UCLB Albion manages the UCL technology fund
AlbionVC typically invests £2m-5m into B2B software companies and marketplaces at Series A.
AlbionVC also manages the UCL Technology Fund, which makes seed stage investments in IP created by UCL. Notable exits to date include Grapeshot (Oracle), Opta (Perform), Active Hotels/ Booking.com (Priceline), Bloomsbury (Facebook) and Orchard Therapeutics (NASDAQ).
AlbionVC typically invests £2m-5m into B2B software companies and marketplaces at Series A.
AlbionVC also manages the UCL Technology Fund, which makes seed stage investments in IP created by UCL. Notable exits to date include Grapeshot (Oracle), Opta (Perform), Active Hotels/ Booking.com (Priceline), Bloomsbury (Facebook) and Orchard Therapeutics (NASDAQ).
AlbionVC typically invests £2m-5m into B2B software companies and marketplaces at Series A.
AlbionVC also manages the UCL Technology Fund, which makes seed stage investments in IP created by UCL. Notable exits to date include Grapeshot (Oracle), Opta (Perform), Active Hotels/ Booking.com (Priceline), Bloomsbury (Facebook) and Orchard Therapeutics (NASDAQ).
AlbionVC typically invests £2m-5m into B2B software companies and marketplaces at Series A.
AlbionVC also manages the UCL Technology Fund, which makes seed stage investments in IP created by UCL. Notable exits to date include Grapeshot (Oracle), Opta (Perform), Active Hotels/ Booking.com (Priceline), Bloomsbury (Facebook) and Orchard Therapeutics (NASDAQ).
Follow us 
